Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Deltagen Research Laboratories

Division of Deltagen Inc.

Latest From Deltagen Research Laboratories

Cerep Moves Beyond Services

Can slow and steady win the drug-discovery race? France's Cerep prepares to find out, as it pushes past its fee-for-service start.
BioPharmaceutical Strategy

CombiChem Squeezes Through a Narrow Exit Door

CombiChem's acquisition by DuPont deal is, somewhat paradoxically, yet further proof of the difficulty that early-stage biotechs will have in finding Big Pharma buyers. Unless discovery biotechs are offering something specifically appropriate to a particular drug firm, even moderately valued acquisitions are unlikely exit opportunities.
BioPharmaceutical Business Strategies

Biotech: Making Money the Old-Fashioned Way

At the January 1999 Hambrecht & Quist meeting, investors were hearing a new message from biotechs: the Millennium-ization of the industry. Platform companies are promising to leverage their technologies much more aggressively for many more customers. They'll identify their assets, sell them, and sell them again.
BioPharmaceutical Strategy

Combinatorial Power

Riccardo Pigliucci, former CEO of Life Sciences International PLC and past president and COO of Perkin Elmer Corp. thinks he has found a model that will serve the small companies' needs to build value, keep up with technological innovation and create large enough operations to make Big pharma feel comfortable in dealing with them. Discovery Partners International is a sort of holding company for drug discovery tool companies. It has made its first investments in combinatorial chemistry company Irori and chemical library provider ChemRx.
BioPharmaceutical Strategy
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • CombiChem Inc.
  • Bristol-Myers Squibb Pharma Research Labs LLC
  • DuPont Pharmaceuticals Research Laboratories
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Deltagen Inc.
  • Senior Management
  • Vicente Anido, PhD , CEO
    Todd Myers, Dir., Fin.
    Peter L Myers, PhD, COO, CSO
    Lee R McCracken, SVP, Corp. Dev. & New Bus. Ventures
    Michael G Rusnak, VP, Bus. Dev.
    Mark Suto, VP, Operations
  • Contact Info
  • Deltagen Research Laboratories
    Phone: (619) 530-0484
    4570 Executive Dr.
    San Diego, CA 92121
    USA
UsernamePublicRestriction

Register